Catalyst Wire Dossier Catalyst Wire Dossier

Rivastigmine Capsule

Rivastigmine · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rivastigmine Capsule, covering 2011-11-28 to 2011-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) [Phase 3]

See pricing